RE: Best Share To Buy IG10 Mar 2023 12:08
We need the numbers to make the final calls and verify RAH’s position. But. A big but; very few others discuss the science and I believe his view to be sound.
The key thing with the SEs is that they’re consistent and appear to be dose agnostic. Viewed in context of other similar drug trials, they’re very good.
Exposure - they’ve told us in big handfuls. Numbers look inline with preclin. All good to me.